Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Chan

Showing results (1-10 of 5,628) with videos related to

Pageof 563
Sort By:
Cancers|March 25, 2022
Novel Perspectives in Immune Checkpoint Inhibitors and the Management of Non-Alcoholic Steatohepatitis-Related Hepatocellular CarcinomaLandon L Chan, Stephen L Chan
The Lancet. Oncology|December 1, 2023
Drug development for hepatocellular carcinomaLandon L Chan, Stephen L Chan
Journal of Hepatology|December 21, 2025
What's next after the 2025 BCLC update?Landon L Chan, Stephen L Chan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2026
Transarterial Chemoembolization and Immunotherapy: Another Good Marriage?Landon L Chan, Stephen L Chan
Liver International : Official Journal of the International Association for the Study of the Liver|January 21, 2023
The combination of ALBI and AFP response: A small step forward in HCCLandon L Chan, Stephen L Chan
Clinical and Molecular Hepatology|March 12, 2023
The prime time for management of hepatocellular carcinoma in Hong KongLandon L Chan, Stephen L Chan
Therapeutic Advances in Medical Oncology|March 27, 2025
Future perspectives on immunotherapy for hepatocellular carcinomaLandon L Chan, Stephen L Chan
Expert Opinion on Emerging Drugs|March 16, 2021
Emerging immune checkpoint inhibitors for the treatment of hepatocellular carcinomaLandon L Chan, Stephen L Chan
Clinical and Molecular Hepatology|May 25, 2023
The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatmentLandon L Chan, Stephen L Chan
Biochimie|January 1, 1995
Apolipoprotein B messenger RNA editing: an updateL Chan
Pageof 563

Showing results (1-10 of 5,628) with videos related to

Sort By:
Pageof 563
Cancers|March 25, 2022
Novel Perspectives in Immune Checkpoint Inhibitors and the Management of Non-Alcoholic Steatohepatitis-Related Hepatocellular CarcinomaLandon L Chan, Stephen L Chan
The Lancet. Oncology|December 1, 2023
Drug development for hepatocellular carcinomaLandon L Chan, Stephen L Chan
Journal of Hepatology|December 21, 2025
What's next after the 2025 BCLC update?Landon L Chan, Stephen L Chan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2026
Transarterial Chemoembolization and Immunotherapy: Another Good Marriage?Landon L Chan, Stephen L Chan
Liver International : Official Journal of the International Association for the Study of the Liver|January 21, 2023
The combination of ALBI and AFP response: A small step forward in HCCLandon L Chan, Stephen L Chan
Clinical and Molecular Hepatology|March 12, 2023
The prime time for management of hepatocellular carcinoma in Hong KongLandon L Chan, Stephen L Chan
Therapeutic Advances in Medical Oncology|March 27, 2025
Future perspectives on immunotherapy for hepatocellular carcinomaLandon L Chan, Stephen L Chan
Expert Opinion on Emerging Drugs|March 16, 2021
Emerging immune checkpoint inhibitors for the treatment of hepatocellular carcinomaLandon L Chan, Stephen L Chan
Clinical and Molecular Hepatology|May 25, 2023
The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatmentLandon L Chan, Stephen L Chan
Biochimie|January 1, 1995
Apolipoprotein B messenger RNA editing: an updateL Chan
Pageof 563